| 1 |
Philip A. Carpino |
Pfizer |
10 |
| 1 |
Gregory J. LaRosa |
Millennium Pharmaceuticals |
10 |
| 3 |
Kevin M. Connolly |
Intel |
7 |
| #4 |
Louis Anthony Tartaglia |
Millennium Pharmaceuticals |
6 |
| #4 |
Joseph M. Jacobson |
E Ink Holdings |
6 |
| #6 |
Stephen L. Buchwald |
MIT |
5 |
| #6 |
William Chura |
The Holmes Group |
5 |
| #6 |
Peter J. Rothschild |
American Science And Engineering |
5 |
| #6 |
Rachel Meyers |
Millennium Pharmaceuticals |
5 |
| #6 |
Yoav Raz |
Emc |
5 |
| #11 |
John C. Costello |
Moen Incorporated |
4 |
| #11 |
David Wu |
Sharkninja Operating |
4 |
| #11 |
H. Barteld Van Rees |
RTX (Raytheon) |
4 |
| #11 |
Leonardus H. T. Van Der Ploeg |
Merck |
4 |
| #11 |
Irena Bronstein |
Tropix |
4 |
| #11 |
Paul Melman |
Gte Laboratories Incorporated |
4 |
| #11 |
David Wolf |
Magnecomp |
4 |
| #11 |
Jungwook Yang |
IBM |
4 |
| #11 |
Christopher J. Dinsmore |
Merck |
4 |
| #20 |
Frederick M. Ausubel |
The General Hospital |
3 |
| #20 |
Karen Sarachik |
Goldpocket Interactive |
3 |
| #20 |
Zoran Cakeljic |
Emc |
3 |
| #20 |
Tatsuhiko Kodama |
Kowa Company |
3 |
| #20 |
Ravi V. J. Chari |
Immunogen |
3 |
| #20 |
Roy Heinz |
Gn Netcom/Unex |
3 |
| #20 |
Richard J. Morris |
Diversi Plast Products |
3 |
| #20 |
Yuri Tuvim |
Waters Investments Limited |
3 |
| #20 |
Philip J. Lin |
Tellabs Operations |
3 |
| #20 |
Yi-Qiao Song |
Schlumberger Technology |
3 |
| #20 |
Jay Werb |
Rf Technologies |
3 |
| #20 |
Erik Wong |
Pharmacia & Upjohn Company |
3 |
| #20 |
Larry R. Brown |
Baxter International |
3 |
| #33 |
Jay Rodney Walton |
Qualcomm |
2 |
| #33 |
Lee M. Nadler |
Dana-Farber Cancer Institute |
2 |
| #33 |
Daniel Elbaum |
Ra Pharmaceuticals |
2 |
| #33 |
Izi Bruker |
Johnson & Johnson |
2 |
| #33 |
Alexey L. Margolin |
Alcresta Therapeutics |
2 |
| #33 |
Uresh K. Vahalia |
Emc |
2 |
| #33 |
Edmond Murad |
US Air Force |
2 |
| #33 |
David Talkin |
Google |
2 |
| #33 |
John T. Potts, Jr. |
The General Hospital |
2 |
| #33 |
Robert S. Meissner |
Merck |
2 |
| #33 |
Michael G. Verga |
Abiomed |
2 |
| #33 |
John Byers |
Digital Fountain |
2 |
| #33 |
Michael W. Kleeman |
Tandem Medical |
2 |
| #33 |
Kenneth J. Rothschild |
Ambergen |
2 |
| #33 |
Yigal Koltin |
Millennium Pharmaceuticals |
2 |
| #33 |
Bertha K. Madras |
Harvard University |
2 |
| #33 |
Eugene S. Rubin |
Bae Systems Information And Electronic Systems Integration |
2 |
| #33 |
Kenneth Jacobs |
Genetics Institute |
2 |